Tapewire

Nasdaq · USD

CCCC

C4 Therapeutics, Inc.

Export transactions ↓
Tapewire entity
5503
SEC CIK
0001662579
Parsed reports
295

Last 12 months

Inside the activity.

0 purchase rows · 1 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202601
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 05, 2021 Filed Apr 6, 2021 16:30 UTC
COHEN MARC ADirector · 10% owner
GrantCommon Stock 553 $37.51 $20,743.03
Disclosure

SEC source: 0001209191-21-025661 · doc4.xml · nonDerivative · entry 1

COHEN MARC A · CIK 0001132945 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,119

F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.

F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on April 5, 2021.

Read SEC document
April 05, 2021 Filed Apr 6, 2021 16:30 UTC GrantCommon Stock 359 $37.51 $13,466.09
Disclosure

SEC source: 0001209191-21-025663 · doc4.xml · nonDerivative · entry 1

Salter Malcolm · CIK 0001825124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,353

F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.

F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on April 5, 2021.

Read SEC document
April 05, 2021 Filed Apr 6, 2021 20:31 UTC GrantCommon Stock 233 $37.51 $8,739.83
Disclosure

SEC source: 0001209191-21-025665 · doc4.xml · nonDerivative · entry 1

Anderson Kenneth Carl · CIK 0001824862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,157

F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.

F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on April 5, 2021.

Read SEC document
April 05, 2021 Filed Apr 6, 2021 20:30 UTC
Crystal AdamChief Medical Officer
Exercise / conversionCommon Stock · Derivative 15,000 $0.00 Strike: $6.50 $0.00
Disclosure

SEC source: 0001209191-21-025664 · doc4.xml · derivative · entry 4

Crystal Adam · CIK 0001825445 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 157,292

Underlying: Common Stock · 15,000 shares

Expires 2029-04-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on January 21, 2021.

F4 · derivative.exercise_date: 25% of this option vested and became exercisable on February 14, 2020, with the remainder vesting in 16 equal quarterly installments thereafter.

Read SEC document
April 05, 2021 Filed Apr 6, 2021 20:30 UTC
Crystal AdamChief Medical Officer
SaleCommon Stock 10,879 $38.00 $413,407.44
Disclosure

SEC source: 0001209191-21-025664 · doc4.xml · nonDerivative · entry 3

Crystal Adam · CIK 0001825445 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on January 21, 2021.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.59 to $38.32. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
April 05, 2021 Filed Apr 6, 2021 20:30 UTC
Crystal AdamChief Medical Officer
SaleCommon Stock 4,121 $37.16 $153,128.53
Disclosure

SEC source: 0001209191-21-025664 · doc4.xml · nonDerivative · entry 2

Crystal Adam · CIK 0001825445 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,879

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on January 21, 2021.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.545 to $37.53. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
April 05, 2021 Filed Apr 6, 2021 20:30 UTC
Crystal AdamChief Medical Officer
Exercise / conversionCommon Stock 15,000 $6.50 $97,500.00
Disclosure

SEC source: 0001209191-21-025664 · doc4.xml · nonDerivative · entry 1

Crystal Adam · CIK 0001825445 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on January 21, 2021.

Read SEC document
March 12, 2021 Filed Mar 16, 2021 16:17 UTC
Dubin GlennDirector
GrantStock Option (Right to Buy) · Derivative 41,200 $0.00 Strike: $44.64 $0.00
Disclosure

SEC source: 0001209191-21-020777 · doc4.xml · derivative · entry 1

Dubin Glenn · CIK 0001308597 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,200

Underlying: Common Stock · 41,200 shares

Expires 2031-03-11

F1 · derivative.exercise_date: One-third of this option shall vest and become exercisable on March 12, 2022, with the remainder vesting in eight equal quarterly installments thereafter.

Read SEC document
February 18, 2021 Filed Feb 19, 2021 16:15 UTC
COHEN MARC ADirector · 10% owner
Exercise / conversionStock Option (Right to Buy) · Derivative 536 $0.00 Strike: $2.11 $0.00
Disclosure

SEC source: 0001209191-21-012339 · doc4.xml · derivative · entry 4

COHEN MARC A · CIK 0001132945 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,209

Underlying: Common Stock · 536 shares

Expires 2026-07-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Represents underlying unexercised stock options that were granted on July 13, 2016. The terms of the original grant provide that 12.5% of this option vested and became exercisable on December 31, 2016, with the remainder vesting in 28 equal quarterly installments thereafter, subject to the Reporting Person's continuous service through each such date.

Read SEC document
February 18, 2021 Filed Feb 19, 2021 16:15 UTC
COHEN MARC ADirector · 10% owner
Exercise / conversionCommon Stock 536 $2.11 $1,130.96
Disclosure

SEC source: 0001209191-21-012339 · doc4.xml · nonDerivative · entry 1

COHEN MARC A · CIK 0001132945 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,566

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 11, 2021 Filed Feb 16, 2021 21:16 UTC
Wahlberg Laura JeanVP of Finance Corp Controller
GrantStock Option (Right to Buy) · Derivative 23,100 $0.00 Strike: $45.54 $0.00
Disclosure

SEC source: 0001209191-21-010711 · doc4.xml · derivative · entry 1

Wahlberg Laura Jean · CIK 0001825153 · VP of Finance Corp Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,100

Underlying: Common Stock · 23,100 shares

Expires 2031-02-10

F1 · derivative.exercise_date: This option shall vest and become exercisable in 16 equal quarterly installments, with the first installment vesting on May 11, 2021.

Read SEC document
February 11, 2021 Filed Feb 16, 2021 21:15 UTC
Fisher StewartChief Scientific Officer
GrantStock Option (Right to Buy) · Derivative 94,950 $0.00 Strike: $45.54 $0.00
Disclosure

SEC source: 0001209191-21-010710 · doc4.xml · derivative · entry 1

Fisher Stewart · CIK 0001824863 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,950

Underlying: Common Stock · 94,950 shares

Expires 2031-02-10

F1 · derivative.exercise_date: This option shall vest and become exercisable in 16 equal quarterly installments, with the first installment vesting on May 11, 2021.

Read SEC document
February 11, 2021 Filed Feb 16, 2021 21:15 UTC
Crystal AdamChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 87,850 $0.00 Strike: $45.54 $0.00
Disclosure

SEC source: 0001209191-21-010707 · doc4.xml · derivative · entry 1

Crystal Adam · CIK 0001825445 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,850

Underlying: Common Stock · 87,850 shares

Expires 2031-02-10

F1 · derivative.exercise_date: This option shall vest and become exercisable in 16 equal quarterly installments, with the first installment vesting on May 11, 2021.

Read SEC document
February 11, 2021 Filed Feb 16, 2021 21:15 UTC
Siegel JolieChief Legal Officer
GrantStock Option (Right to Buy) · Derivative 84,850 $0.00 Strike: $45.54 $0.00
Disclosure

SEC source: 0001209191-21-010708 · doc4.xml · derivative · entry 1

Siegel Jolie · CIK 0001768223 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,850

Underlying: Common Stock · 84,850 shares

Expires 2031-02-10

F1 · derivative.exercise_date: This option shall vest and become exercisable in 16 equal quarterly installments, with the first installment vesting on May 11, 2021.

Read SEC document
February 03, 2021 Filed Feb 4, 2021 21:35 UTC
Fisher StewartChief Scientific Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 5,929 $0.00 Strike: $3.71 $0.00
Disclosure

SEC source: 0001209191-21-007740 · doc4.xml · derivative · entry 8

Fisher Stewart · CIK 0001824863 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,514

Underlying: Common Stock · 5,929 shares

Expires 2028-04-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Form 3 filed on October 1, 2020 included an incorrect exercise price in Table II, Column 2 ($3.72).

F3 · derivative.exercise_date: Represents underlying unexercised stock options that were granted on April 24, 2018. The terms of the original grant provide that 20% of this option vested and became exercisable on May 1, 2019, with the remainder vesting in 16 equal quarterly installments thereafter.

Read SEC document
February 03, 2021 Filed Feb 4, 2021 21:35 UTC
Fisher StewartChief Scientific Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 2,371 $0.00 Strike: $2.11 $0.00
Disclosure

SEC source: 0001209191-21-007740 · doc4.xml · derivative · entry 7

Fisher Stewart · CIK 0001824863 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,371

Underlying: Common Stock · 2,371 shares

Expires 2026-07-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Represents underlying unexercised stock options that were granted on July 13, 2016. The terms of the original grant provide that 20% of this option vested and became exercisable on May 2, 2017, with the remainder vesting in 16 equal quarterly installments thereafter.

Read SEC document
February 03, 2021 Filed Feb 4, 2021 21:35 UTC
Fisher StewartChief Scientific Officer
Exercise / conversionCommon Stock 5,929 $3.71 $21,996.59
Disclosure

SEC source: 0001209191-21-007740 · doc4.xml · nonDerivative · entry 4

Fisher Stewart · CIK 0001824863 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,116

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Form 3 filed on October 1, 2020 included an incorrect exercise price in Table II, Column 2 ($3.72).

Read SEC document
February 03, 2021 Filed Feb 4, 2021 21:35 UTC
Fisher StewartChief Scientific Officer
Exercise / conversionCommon Stock 2,371 $2.11 $5,002.81
Disclosure

SEC source: 0001209191-21-007740 · doc4.xml · nonDerivative · entry 3

Fisher Stewart · CIK 0001824863 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,187

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 22, 2021 Filed Jan 26, 2021 21:34 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 889 $0.00 Strike: $4.98 $0.00
Disclosure

SEC source: 0001209191-21-005374 · doc4.xml · derivative · entry 11

Anderson Kenneth Carl · CIK 0001824862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,446

Underlying: Common Stock · 889 shares

Expires 2030-07-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: This option shall vest and become exercisable in 12 equal quarterly installments, with the first installment vesting on October 1, 2020.

Read SEC document
January 22, 2021 Filed Jan 26, 2021 21:34 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 121 $0.00 Strike: $2.11 $0.00
Disclosure

SEC source: 0001209191-21-005374 · doc4.xml · derivative · entry 10

Anderson Kenneth Carl · CIK 0001824862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 121 shares

Expires 2026-07-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · shares: The Form 3 filed on October 1, 2020 included an incorrect number of underlying securities in Table II, Column 3 (118).

F7 · derivative.exercise_date: Represents underlying unexercised stock options that were granted on July 13, 2016. The terms of the original grant provide that 20% of this option vested and became exercisable on January 1, 2017, with the remainder vesting in 16 equal quarterly installments thereafter.

F6 · derivative.underlying_shares: The Form 3 filed on October 1, 2020 included an incorrect number of underlying securities in Table II, Column 3 (118).

Read SEC document
January 22, 2021 Filed Jan 26, 2021 21:34 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 538 $0.00 Strike: $2.11 $0.00
Disclosure

SEC source: 0001209191-21-005374 · doc4.xml · derivative · entry 9

Anderson Kenneth Carl · CIK 0001824862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,207

Underlying: Common Stock · 538 shares

Expires 2026-07-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Represents underlying unexercised stock options that were granted on July 13, 2016. The terms of the original grant provide that 12.5% of this option vested and became exercisable on December 31, 2016, with the remainder vesting in 28 equal quarterly installments thereafter.

Read SEC document
January 22, 2021 Filed Jan 26, 2021 21:34 UTC Exercise / conversionCommon Stock 889 $4.98 $4,427.22
Disclosure

SEC source: 0001209191-21-005374 · doc4.xml · nonDerivative · entry 3

Anderson Kenneth Carl · CIK 0001824862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,924

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 22, 2021 Filed Jan 26, 2021 21:34 UTC Exercise / conversionCommon Stock 121 $2.11 $255.31
Disclosure

SEC source: 0001209191-21-005374 · doc4.xml · nonDerivative · entry 2

Anderson Kenneth Carl · CIK 0001824862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,035

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 22, 2021 Filed Jan 26, 2021 21:34 UTC Exercise / conversionCommon Stock 538 $2.11 $1,135.18
Disclosure

SEC source: 0001209191-21-005374 · doc4.xml · nonDerivative · entry 1

Anderson Kenneth Carl · CIK 0001824862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,914

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 11, 2020 Filed Feb 4, 2021 21:35 UTC
Fisher StewartChief Scientific Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 9,701 $0.00 Strike: $3.71 $0.00
Disclosure

SEC source: 0001209191-21-007740 · doc4.xml · derivative · entry 6

Fisher Stewart · CIK 0001824863 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,443

Underlying: Common Stock · 9,701 shares

Expires 2028-04-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Form 3 filed on October 1, 2020 included an incorrect exercise price in Table II, Column 2 ($3.72).

F3 · derivative.exercise_date: Represents underlying unexercised stock options that were granted on April 24, 2018. The terms of the original grant provide that 20% of this option vested and became exercisable on May 1, 2019, with the remainder vesting in 16 equal quarterly installments thereafter.

Read SEC document
December 11, 2020 Filed Feb 4, 2021 21:35 UTC
Fisher StewartChief Scientific Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 4,743 $0.00 Strike: $2.11 $0.00
Disclosure

SEC source: 0001209191-21-007740 · doc4.xml · derivative · entry 5

Fisher Stewart · CIK 0001824863 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,742

Underlying: Common Stock · 4,743 shares

Expires 2026-07-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Represents underlying unexercised stock options that were granted on July 13, 2016. The terms of the original grant provide that 20% of this option vested and became exercisable on May 2, 2017, with the remainder vesting in 16 equal quarterly installments thereafter.

Read SEC document
December 11, 2020 Filed Feb 4, 2021 21:35 UTC
Fisher StewartChief Scientific Officer
Exercise / conversionCommon Stock 9,701 $3.71 $35,990.71
Disclosure

SEC source: 0001209191-21-007740 · doc4.xml · nonDerivative · entry 2

Fisher Stewart · CIK 0001824863 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,816

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Form 3 filed on October 1, 2020 included an incorrect exercise price in Table II, Column 2 ($3.72).

Read SEC document
December 11, 2020 Filed Feb 4, 2021 21:35 UTC
Fisher StewartChief Scientific Officer
Exercise / conversionCommon Stock 4,743 $2.11 $10,007.73
Disclosure

SEC source: 0001209191-21-007740 · doc4.xml · nonDerivative · entry 1

Fisher Stewart · CIK 0001824863 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,115

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 06, 2020 Filed Oct 6, 2020 21:24 UTC
COHEN ALAIN JDirector · 10% owner
ConversionSeries B Preferred Stock · Derivative 20,952,403 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-027690 · doc4.xml · derivative · entry 6

COHEN ALAIN J · CIK 0001132946 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Cobro Ventures Opportunity Fund, L.P.

Disclosed balance after: 0

Underlying: Common Stock · 2,484,425 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

F1 · derivative.exercise_date: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

F1 · derivative.expiration_date: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

F3 · ownership.nature: Shares held by Cobro Ventures Opportunity Fund, L.P. ("Cobro Ventures"). The Reporting Person serves as a manager of Cobro Opportunity Fund GP, LLC, the general partner of Cobro Ventures, and may be deemed to exercise voting and investment power over the shares held by Cobro Ventures. The Reporting Person disclaims beneficial ownership of the shares held by Cobro Ventures except to the extent of his pecuniary interest therein.

Read SEC document
October 06, 2020 Filed Oct 6, 2020 21:24 UTC
COHEN ALAIN JDirector · 10% owner
ConversionSeries A Preferred Stock · Derivative 12,500,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-027690 · doc4.xml · derivative · entry 5

COHEN ALAIN J · CIK 0001132946 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 1,482,183 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

F1 · derivative.exercise_date: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

F1 · derivative.expiration_date: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

F2 · ownership.nature: Shares held by the Reporting Person as trustee of the Alain J. Cohen Revocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
October 06, 2020 Filed Oct 6, 2020 21:24 UTC
COHEN ALAIN JDirector · 10% owner
ConversionSeries Seed Preferred Stock · Derivative 2,000,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-027690 · doc4.xml · derivative · entry 4

COHEN ALAIN J · CIK 0001132946 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 237,149 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

F1 · derivative.exercise_date: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

F1 · derivative.expiration_date: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

F2 · ownership.nature: Shares held by the Reporting Person as trustee of the Alain J. Cohen Revocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
October 06, 2020 Filed Oct 6, 2020 21:24 UTC
COHEN ALAIN JDirector · 10% owner
ConversionCommon Stock 2,484,425 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-20-027690 · doc4.xml · nonDerivative · entry 3

COHEN ALAIN J · CIK 0001132946 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Cobro Ventures Opportunity Fund, L.P.

Disclosed balance after: 2,484,425

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

F3 · ownership.nature: Shares held by Cobro Ventures Opportunity Fund, L.P. ("Cobro Ventures"). The Reporting Person serves as a manager of Cobro Opportunity Fund GP, LLC, the general partner of Cobro Ventures, and may be deemed to exercise voting and investment power over the shares held by Cobro Ventures. The Reporting Person disclaims beneficial ownership of the shares held by Cobro Ventures except to the extent of his pecuniary interest therein.

Read SEC document
October 06, 2020 Filed Oct 6, 2020 21:24 UTC
COHEN ALAIN JDirector · 10% owner
ConversionCommon Stock 1,482,183 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-20-027690 · doc4.xml · nonDerivative · entry 2

COHEN ALAIN J · CIK 0001132946 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,719,332

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

F2 · ownership.nature: Shares held by the Reporting Person as trustee of the Alain J. Cohen Revocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
October 06, 2020 Filed Oct 6, 2020 21:24 UTC
COHEN ALAIN JDirector · 10% owner
ConversionCommon Stock 237,149 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-20-027690 · doc4.xml · nonDerivative · entry 1

COHEN ALAIN J · CIK 0001132946 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 237,149

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

F2 · ownership.nature: Shares held by the Reporting Person as trustee of the Alain J. Cohen Revocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
October 06, 2020 Filed Oct 6, 2020 21:28 UTC
COHEN MARC ADirector · 10% owner
ConversionSeries B Preferred Stock · Derivative 20,952,403 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-027697 · doc4.xml · derivative · entry 7

COHEN MARC A · CIK 0001132945 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Cobro Ventures Opportunity Fund, L.P.

Disclosed balance after: 0

Underlying: Common Stock · 2,484,425 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

F1 · derivative.exercise_date: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

F1 · derivative.expiration_date: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

F3 · ownership.nature: Shares held by Cobro Ventures Opportunity Fund, L.P. ("Cobro Ventures"). The Reporting Person serves as a manager of Cobro Opportunity Fund GP, LLC, the general partner of Cobro Ventures, and may be deemed to exercise voting and investment power over the shares held by Cobro Ventures. The Reporting Person disclaims beneficial ownership of the shares held by Cobro Ventures except to the extent of his pecuniary interest therein.

Read SEC document
October 06, 2020 Filed Oct 6, 2020 21:28 UTC
COHEN MARC ADirector · 10% owner
ConversionSeries A Preferred Stock · Derivative 12,500,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-027697 · doc4.xml · derivative · entry 6

COHEN MARC A · CIK 0001132945 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 1,482,183 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

F1 · derivative.exercise_date: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

F1 · derivative.expiration_date: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

F2 · ownership.nature: Shares held by Reporting Person as trustee of the Marc Andrew Cohen Revocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
October 06, 2020 Filed Oct 6, 2020 21:28 UTC
COHEN MARC ADirector · 10% owner
ConversionSeries Seed Preferred Stock · Derivative 2,000,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-027697 · doc4.xml · derivative · entry 5

COHEN MARC A · CIK 0001132945 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 237,149 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

F1 · derivative.exercise_date: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

F1 · derivative.expiration_date: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

F2 · ownership.nature: Shares held by Reporting Person as trustee of the Marc Andrew Cohen Revocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
October 06, 2020 Filed Oct 6, 2020 21:28 UTC
COHEN MARC ADirector · 10% owner
PurchaseCommon Stock 5,030 $19.00 $95,570.00
Disclosure

SEC source: 0000899243-20-027697 · doc4.xml · nonDerivative · entry 4

COHEN MARC A · CIK 0001132945 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,030

Read SEC document
October 06, 2020 Filed Oct 6, 2020 21:28 UTC
COHEN MARC ADirector · 10% owner
ConversionCommon Stock 2,484,425 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-20-027697 · doc4.xml · nonDerivative · entry 3

COHEN MARC A · CIK 0001132945 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Cobro Ventures Opportunity Fund, L.P.

Disclosed balance after: 2,484,425

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

F3 · ownership.nature: Shares held by Cobro Ventures Opportunity Fund, L.P. ("Cobro Ventures"). The Reporting Person serves as a manager of Cobro Opportunity Fund GP, LLC, the general partner of Cobro Ventures, and may be deemed to exercise voting and investment power over the shares held by Cobro Ventures. The Reporting Person disclaims beneficial ownership of the shares held by Cobro Ventures except to the extent of his pecuniary interest therein.

Read SEC document
October 06, 2020 Filed Oct 6, 2020 21:28 UTC
COHEN MARC ADirector · 10% owner
ConversionCommon Stock 1,482,183 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-20-027697 · doc4.xml · nonDerivative · entry 2

COHEN MARC A · CIK 0001132945 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,852,207

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

F2 · ownership.nature: Shares held by Reporting Person as trustee of the Marc Andrew Cohen Revocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
October 06, 2020 Filed Oct 6, 2020 21:28 UTC
COHEN MARC ADirector · 10% owner
ConversionCommon Stock 237,149 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-20-027697 · doc4.xml · nonDerivative · entry 1

COHEN MARC A · CIK 0001132945 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 370,024

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

F2 · ownership.nature: Shares held by Reporting Person as trustee of the Marc Andrew Cohen Revocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Read SEC document
October 06, 2020 Filed Oct 6, 2020 21:26 UTC ConversionSeries B Preferred Stock · Derivative 23,809 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-027692 · doc4.xml · derivative · entry 5

Salter Malcolm · CIK 0001825124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,823 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

F1 · derivative.exercise_date: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

F1 · derivative.expiration_date: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

Read SEC document
October 06, 2020 Filed Oct 6, 2020 21:26 UTC ConversionSeries A Preferred Stock · Derivative 100,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-027692 · doc4.xml · derivative · entry 4

Salter Malcolm · CIK 0001825124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,856 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

F1 · derivative.exercise_date: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

F1 · derivative.expiration_date: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

Read SEC document
October 06, 2020 Filed Oct 6, 2020 21:26 UTC PurchaseCommon Stock 1,315 $19.00 $24,985.00
Disclosure

SEC source: 0000899243-20-027692 · doc4.xml · nonDerivative · entry 3

Salter Malcolm · CIK 0001825124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,994

Read SEC document
October 06, 2020 Filed Oct 6, 2020 21:26 UTC ConversionCommon Stock 2,823 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-20-027692 · doc4.xml · nonDerivative · entry 2

Salter Malcolm · CIK 0001825124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,679

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

Read SEC document
October 06, 2020 Filed Oct 6, 2020 21:26 UTC ConversionCommon Stock 11,856 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-20-027692 · doc4.xml · nonDerivative · entry 1

Salter Malcolm · CIK 0001825124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,856

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

Read SEC document
October 06, 2020 Filed Oct 6, 2020 21:27 UTC
DOWNEY BRUCEDirector
ConversionSeries B Preferred Stock · Derivative 2,128,571 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-027695 · doc4.xml · derivative · entry 4

DOWNEY BRUCE · CIK 0001237257 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 252,394 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

F1 · derivative.exercise_date: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

F1 · derivative.expiration_date: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

Read SEC document
October 06, 2020 Filed Oct 6, 2020 21:27 UTC
DOWNEY BRUCEDirector
ConversionSeries A Preferred Stock · Derivative 2,000,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-027695 · doc4.xml · derivative · entry 3

DOWNEY BRUCE · CIK 0001237257 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 237,148 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

F1 · derivative.exercise_date: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

F1 · derivative.expiration_date: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

Read SEC document
October 06, 2020 Filed Oct 6, 2020 21:27 UTC
DOWNEY BRUCEDirector
ConversionCommon Stock 252,394 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-20-027695 · doc4.xml · nonDerivative · entry 2

DOWNEY BRUCE · CIK 0001237257 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 489,542

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

Read SEC document
October 06, 2020 Filed Oct 6, 2020 21:27 UTC
DOWNEY BRUCEDirector
ConversionCommon Stock 237,148 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-20-027695 · doc4.xml · nonDerivative · entry 1

DOWNEY BRUCE · CIK 0001237257 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 237,148

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.